These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 7474922)

  • 41. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
    Oude Ophuis MB; Manni JJ; Peters WH
    Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of glutathione S-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomas.
    Chen YK; Lin LM
    Int J Oral Maxillofac Surg; 1997 Jun; 26(3):205-9. PubMed ID: 9180231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue.
    Terrier P; Townsend AJ; Coindre JM; Triche TJ; Cowan KH
    Am J Pathol; 1990 Oct; 137(4):845-53. PubMed ID: 1977319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
    Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
    Cloos J; Snow GB; Braakhuis BJ
    Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-cancer drug resistance and glutathione S-transferases].
    Sato K; Tsuchida S; Tamai K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical demonstration of epithelial glutathione S-transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa.
    Chen YK; Lin LM
    J Oral Pathol Med; 1995 Aug; 24(7):316-21. PubMed ID: 7473269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutathione S-transferase detoxication enzymes in cervical neoplasia.
    Carder PJ; al-Nafussi A; Rahilly M; Lauder J; Harrison DJ
    J Pathol; 1990 Dec; 162(4):303-8. PubMed ID: 2290115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
    Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
    J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT; Carey TE
    J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human leukocyte glutathione S-transferase isozyme (class mu) and susceptibility to smoking-related cancers.
    Soni MG; Krishna TP; Krishnaswamy K
    J Toxicol Environ Health; 1995 Sep; 46(1):1-8. PubMed ID: 7666488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced risk of head and neck second primary tumors after radiotherapy.
    Rennemo E; Zätterström U; Evensen J; Boysen M
    Radiother Oncol; 2009 Dec; 93(3):559-62. PubMed ID: 19747745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary thioether excretion and erythrocyte glutathione S-transferase activities in smokers and patients with squamous-cell laryngeal cancer.
    Kuralay F; Yildiz T
    J Toxicol Environ Health A; 2001 Nov; 64(6):447-52. PubMed ID: 11732695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human-in-mouse modeling of primary head and neck squamous cell carcinoma.
    Law JH; Whigham AS; Wirth PS; Liu D; Pham MQ; Vadivelu S; Kirkbride KC; Brown BT; Burkey BB; Sinard RJ; Netterville JL; Yarbrough WG
    Laryngoscope; 2009 Dec; 119(12):2315-23. PubMed ID: 19693929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma.
    Koch FP; Kämmerer PW; Kämmerer P; Al-Nawas B; Brieger J
    Oral Oncol; 2010 Feb; 46(2):128-33. PubMed ID: 20060357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Second primary carcinomas in the upper aerodigestive tract in different locations and age groups].
    Schwager K; Nebel A; Baier G; Hoppe F
    Laryngorhinootologie; 2000 Oct; 79(10):599-603. PubMed ID: 11089209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetic predisposition for the development of head and neck carcinomas].
    Jahnke V; Matthias C; Bockmühl U; Strange RC
    Laryngorhinootologie; 1999 Jan; 78(1):24-7. PubMed ID: 10080124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics of patients with epidermoid carcinoma of the upper aerodigestive tract who develop second malignant tumors.
    Robinson E; Zauber A; Fuks Z; Strong E
    Cancer Detect Prev; 1992; 16(5-6):297-303. PubMed ID: 1473119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypofolatemia as a risk factor for head and neck cancer.
    Paludetti G; Almadori G; Bussu F; Galli J; Cadoni G; Maurizi M
    Adv Otorhinolaryngol; 2005; 62():12-24. PubMed ID: 15608414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.